The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $56.85

Today's change+0.35 +0.62%
Updated April 28 4:02 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $56.85

Today's change+0.35 +0.62%
Updated April 28 4:02 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc up (U.S.)$0.35

USANA Health Sciences Inc closed up Friday by (U.S.)$0.35 or 0.62% to (U.S.)$56.85. Over the last five days, shares have gained 0.62%, but are down 7.11% for the last year to date. Shares have underperformed the S&P 500 by 20.69% during the last year.

Key company metrics

  • Open(U.S.) $56.65
  • Previous close(U.S.) $56.50
  • High(U.S.) $57.20
  • Low(U.S.) $56.10
  • Bid / Ask-- / --
  • YTD % change-7.11%
  • Volume202,048
  • Average volume (10-day)300,324
  • Average volume (1-month)156,054
  • Average volume (3-month)116,826
  • 52-week range(U.S.) $52.55 to (U.S.) $75.00
  • Beta1.06
  • Trailing P/E14.23×
  • P/E 1 year forward13.88×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.99
Updated April 28 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.94%

Based on its net profit margin of 9.94%, USANA Health Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.51%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Oct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016
Revenue253254259240
Total other revenue--------
Total revenue253254259240
Gross profit207209213198
Total cost of revenue46454643
Total operating expense221218221207
Selling / general / administrative175173175164
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income32363734
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax32363833
Income after tax22302622
Income tax, total1061211
Net income22302622
Total adjustments to net income--------
Net income before extra. items22302622
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22302622
Inc. avail. to common incl. extra. items22302622
Diluted net income22302622
Dilution adjustment--------
Diluted weighted average shares25252525
Diluted EPS excluding extraordinary itemsvalue per share0.871.201.030.89
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.871.201.030.89